Anti-Vertigo Preparations

5 Drugs classified under this therapeutic system

H1 Agonist. Betahistine (dihydrochloride) 16 mg.
SCORED TABS: 30 x 16 mg. 1/2-1 tab. 3 x
dly. Maint: up to 1 tab. 3 x dly.
Meniere’s dis., Meniere’s-like syndr.,
characterized by vertigo, tinnitus and/or
progress. hear. loss, sympt. tmt. periph.
vertigo.
C/I: Hypersens., pheochromocytoma

H1 Agonist. Betahistine 16 mg.
TABS: 30. Initial: 8 mg 3 x dly. Maint:
8-16 mg 3 x dly.
Meniere’s syndr, sympt. tmt. of periph.
vertigo
C/I: Hypersens. to prod.,
pheochromocytoma.

H1 Agonist. Betahistine (as HCl) 16 mg.
TABS: 30. Initial: 8-16 mg 3 x dly. Maint:
24-48 mg dly.
Meniere’s syndr, characterized by vertigo,
tinitus and/or hear. impair, sympt. tmt.
periph vertigo.

Antipsychotic, Atypical Antipsychotic, Substituted Benzamide. Sulpiride 50 mg, 200 mg.
CAPS: 30 x 50 mg. See lit.
Schizophren. states with sympt. of
apathy and apragmatism, acute
confusional states, depress. states of
various origins incl. geriat. cases,
neurosis with psychomotoric inhibit.,
childhood and adolesc. psychoses,
prepsychotic states.
C/I: Acute agitat., hypertens.,
pheochromocytoma, Parkinsonism.
TABS: 40 x 200 mg. See lit.
Anti – dopamine. agent: 1. For use in
peptic ulcer and vomit., vertigo,
prepsych. states. 2. At high doses - in
psychiatric pts. for tmt. of depress. and
apathy.
C/I: Hypersens.; Pre-exist. CNS depress.
or coma; Pheochromacytoma, Acute
agitation or mania, HTN; use of alcohol,
barbiturates, opioids etc.

Antiemetic. Cinnarizine 25 mg.
TABS: 25.
Dis. of balance: Adults: 1 tab. x 25 mg
t.i.d. Motion sickn.: Adults: 1 tab. x 25
mg 30 min. bef. travel. every 6 hrs.
Child. (5-12): 1/2 adult dose recomm.
Naus. and vertigo due to Meniere’s syndr.
and other labyrinth. disturb.
C/I: Hypersens.